<DOC>
	<DOC>NCT00656539</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs and symptoms of blepharitis.</brief_summary>
	<brief_title>Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>diagnosis of moderate to severe chronic posterior blepharitis If female of childbearing potential, are nonpregnant and nonlactating had ocular surface surgery (LASIK, refractive, pterygium) within the past year unwilling to discontinue use of contact lenses during the study have glaucoma unable or unwilling to withhold the use of eyelid scrubs during the study have a serious systemic disease or uncontrolled medical condition that in the judgment of the investigator could confound study assessments or limit compliance currently using any preserved topical ocular medications (with the exception of unpreserved tear substitutes) at the time of entry into the study or during study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>